Cannabidiol treatment for refractory epilepsies in pediatrics
U Raucci, N Pietrafusa, MC Paolino… - Frontiers in …, 2020 - frontiersin.org
Cannabis extracts in oil are becoming increasingly available, and, during the last years,
there has been growing public and scientific interest about therapeutic properties of these …
there has been growing public and scientific interest about therapeutic properties of these …
[HTML][HTML] Neurostimulation treatments for epilepsy: Deep brain stimulation, responsive neurostimulation and vagus nerve stimulation
Epilepsy is a common and debilitating neurological disorder, and approximately one-third of
affected individuals have ongoing seizures despite appropriate trials of two anti-seizure …
affected individuals have ongoing seizures despite appropriate trials of two anti-seizure …
Responsive neurostimulation in pediatric patients with drug-resistant epilepsy
N Falls, JI Arango, PD Adelson - Neurosurgical Focus, 2022 - thejns.org
OBJECTIVE Medically refractory epilepsy remains a therapeutic challenge when resective
surgery is not a practical option and indirect neurostimulation efficacy may be limited. In …
surgery is not a practical option and indirect neurostimulation efficacy may be limited. In …
Gentiopicroside alleviated epileptogenesis in immature rats through inactivation of NLRP3 inflammasome by inhibiting P2X7R expression
W Yang, L Ma, S Xu, P Zheng, J Du… - International Journal …, 2023 - Wiley Online Library
Objectives This study aimed to elucidate the effects of Gentiopicroside (Gent) on
epileptogenesis and underlying mechanisms. Methods The status epilepticus (SE) model …
epileptogenesis and underlying mechanisms. Methods The status epilepticus (SE) model …
[HTML][HTML] Real-life experience with purified cannabidiol treatment for refractory epilepsy: a multicenter retrospective study
M Tzadok, R Gur-Pollack, H Florh, Y Michaeli… - Pediatric Neurology, 2024 - Elsevier
Introduction Drug-resistant epilepsy (DRE) significantly affects the development and quality
of life of children and young adults. Objective To describe the effectiveness and safety of …
of life of children and young adults. Objective To describe the effectiveness and safety of …
In Vivo Evaluation of Self-assembled nano-Saikosaponin-a for Epilepsy Treatment
X Liu, Y Zhao, X Liang, Y Ding, J Hu, N Deng… - Molecular …, 2023 - Springer
Saikosaponin-a (SSa) exhibits antiepileptic effects. However, its poor water solubility and
inability to pass through the blood–brain barrier greatly limit its clinical development and …
inability to pass through the blood–brain barrier greatly limit its clinical development and …
[HTML][HTML] Gluten-Free, Casein-Free Diet for Children with Autism Spectrum Disorder: A Case-Controlled Study
K Saad, I Shabaan, MH Abd-El-Monem… - Journal of Pharmacy …, 2024 - journals.lww.com
Materials and Methods: The present clinical trial was conducted as a prospective 12-month,
open-label, case-controlled interventional study. Thirty-six ASD children who were newly …
open-label, case-controlled interventional study. Thirty-six ASD children who were newly …
Arisaema Cum Bile possesses significantly antiepileptic effects through regulation of PI3K/Akt/Nrf2 signaling pathways
L Zhong, C He, M Li, X Wu, Y Gou, Z Geng… - Journal of Taibah …, 2024 - Taylor & Francis
This paper intended to study the mechanism and active ingredients of ACB anti-epilepsy.
The antiepileptic activity of ACB validated in PTZ kindled rats, ACB could increase the …
The antiepileptic activity of ACB validated in PTZ kindled rats, ACB could increase the …
Innovative LC-MS/MS method for therapeutic drug monitoring of fenfluramine and cannabidiol in the plasma of pediatric patients with epilepsy
We present a novel liquid chromatography-tandem mass spectrometry (LC-MS/MS) method
for quantifying fenfluramine (FFA), its active metabolite norfenfluramine (norFFA), and …
for quantifying fenfluramine (FFA), its active metabolite norfenfluramine (norFFA), and …
Pulsatile corticoid therapy reduces interictal epileptic activity burden in children with genetic drug‐resistant epilepsy
Objective Corticosteroids and adrenocorticotropic hormone (ACTH) are the therapy of
choice to treat infantile spasms. However, systematic studies about their use in other types of …
choice to treat infantile spasms. However, systematic studies about their use in other types of …